Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease Case Study 转化药理学咨询支持治疗肺分枝杆菌复合病的联合疗法 RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…Danielle Pillsbury2023 年 5 月 9 日
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges On-Demand Webinar 治疗蛋白质的药物间相互作用:最新情况与挑战 Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…Becca Bucci2022 年 12 月 5 日
Why you should select your drug formulation before starting clinical studies Blog 为何应在开始临床研究前选择药物制剂 Drug developers often rush through the discovery process to get into human testing. Most are…Becca Bucci2022 年 10 月 28 日
3 Takeaways from the FDA Oligo Guidance You Need to Know Blog 3 Takeaways from the FDA Oligo Guidance You Need to Know In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…Becca Bucci2022 年 9 月 23 日
The Essential Components of Your Drug’s Biomarker Strategy White Paper The Essential Components of Your Drug’s Biomarker Strategy Jim Gallagher2022 年 1 月 14 日
Predicting and Taming Immunogenicity: Strategies for your Biologic Drug On-Demand Webinar 预测和驯化免疫原性:生物药物策略 Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…Jim Gallagher2021 年 11 月 19 日
Dose Optimization Using Population PK for an Orphan Drug Case Study Dose Optimization Using Population PK for an Orphan Drug RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…Jim Gallagher2021 年 11 月 17 日
A Day in the Life of a Clinical Pharmacology Consultant Blog 临床药理学顾问的日常一天 Strategic consulting within drug discovery and development is an exciting career choice for many. Unlike…Jim Gallagher2021 年 10 月 8 日
Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs Blog Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs Alzheimer's disease (AD) is one of the most common forms of neurodegenerative dementia in the…Jim Gallagher2021 年 9 月 20 日
生物制剂的临床药理计划是怎样的? 网络研讨会点播 生物制剂的临床药理计划是怎样的? Monoclonal antibodies are now widely used in the treatment of several diseases, providing effective and…Jim Gallagher2021 年 8 月 6 日